Although these findings do not allow us to determine whether napsin A is useful for predicting the outcome in IPF yet, they support the hypothesis that napsin A is a candidate biomarker for diagnosing the presence of disease in an individual. Here, NAPSA is linked to idiopathic pulmonary fibrosis.